A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy

Brachytherapy

Volumn 5, Issue 4, 2006, Pages 244-250

  Heysek, Randy V ^a,b   Gwede, Clement K ^a,b   Torres Roca, Javier ^a   Cantor, Alan ^a   Kelley, Stacey ^a   Saini, Amarjit S ^a   Pow Sang, Julio ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Central Florida Cancer Institute   (United States)

Author keywords

Brachytherapy; Dosimetry; Prostate cancer

Indexed keywords

IODINE 125; PALLADIUM 103; RADIOACTIVE MATERIAL;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOSIMETRY; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PARAMETER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; RADIATION INJURY; RADIATION SAFETY; RETROSPECTIVE STUDY; TRANSPERINEAL INTERSTITIAL PERMANENT PROSTATE SEED BRACHYTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PALLADIUM; PERINEUM; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOMETRY; RETROSPECTIVE STUDIES;

EID: 33750993462     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2006.08.003     Document Type: Article

References (24)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Cooperberg M., Lubeck D., Meng M., et al. The changing face of low risk prostate cancer: Trends in clinical presentation and primary management. J Clin Oncol 22 (2004) 2141-2149
3. O'Leary M.P., Baum N.H., Blizzard R., et al. 2001 American Urological Association Gallup Survey: Changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction. J Urol 68 (2002) 649-652
4. Grimm P., and Sylvester J. Advances in brachytherapy. Rev Urol 6 Suppl. 4 (2004) 537-548
5. Amling C.L., Blute M.L., Lerner S.E., et al. Influence of prostatic-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a larger referral practice. Mayo Clin Proc 73 (1998) 401-406
6. Sharkey J., Chovnick S.D., Behar R.J., et al. Evolution of techniques for ultrasound guided 103 Pd brachytherapy in 950 patients with prostate cancer. Tech Urol 6 (2000) 128-134
7. Grado G.L., Larson T.R., Balch C.S., et al. Actuarial disease free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys 42 (1998) 289-298
8. 125I prostate implants. Radiother Oncol 66 (2003) 173-179
9. Lee L.N., Stock R.G., and Stone N. Role of hormonal therapy in the management of intermediate to high risk prostate cancer treated with permanent radioactive seed implantation. Int J Radiat Oncol Biol Phys 52 (2002) 444-452
10. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources: Recommendation of the AAPM Radiation Therapy Committee Task Force Group # 43. Med Phys 22 (1995) 209-234
11. McMillan S.C., and Bartkowski-Doda L. Measuring bowel elimination. In: Frank-Stromberg M., and Olsen S. (Eds). Instruments for clinical research in health care (1997), Jones & Bartlett Inc., Wilsonville, OR 435-444
12. Nag S., Erickson B., Parikh S., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 48 (2000) 779-790
13. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy post implant dosimetric analysis. Int J Radiat Oncol Biol Phys 46 (2000) 221-230
14. Potters L., Cao Y., Calugaru E., et al. A comprehensive review of CT based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 50 (2001) 605-614
15. Stock R.G., Stone N.M., Loyc, et al. Post implant dosimetry for I-125 prostate implants: Definitions and factors affecting outcome. Int J Radiat Oncol Biol Phys 48 (2000) 899-906
16. 103Pd for low risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys 57 (2003) 1297-1303
17. Lee R.W., deGuzman A.F., Tomlinson S.K., et al. Radioactive sources embedded in suture are associated with improved post implant dosimetry in men treated with prostate brachytherapy. Radiother Oncol 65 (2002) 123-127
18. Fagundes H.M., Keys R., Wojcik M., et al. Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPID strand: A dosimetric analysis. Brachytherapy 3 (2004) 136-140
19. Eshleman J.S., Davis B.J., Pisansky T.M., et al. Radioactive seed migration to the chest following transperineal interstitial prostate brachytherapy: Extraprostatic seed placement correlates with migration. Int J Radiat Oncol Biol Phys 59 (2004) 419-425
20. Merrick J.S., Butler W.M., and Dorsey A.T. Seed fixity in the periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys 46 (2000) 215-220
21. Davis B.J., Bresnahan J.F., Stafford S.L., et al. Prostate brachytherapy seed migration to a coronary artery found during angiography. J Urol 168 (2002) 1103
22. Tapen E.M., Blasko J.C., Grimm P., et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys 42 (1998) 1063-1067
23. Fuller D.B., and Koziol J.A. Prostate brachytherapy seed migration and dosimetry: Analysis of potential predictive factors. Brachytherapy 2 (2003) 47
24. Reed D.R., Mueller A., Wallner, et al. Rapid strand vs. loose (iodine-125 seeds): A prospective randomized trial. Int J Radiat Oncol Biol Phys 60 Suppl (2004) 461